Mali International Center for Excellence in Research: Malaria Research
马里国际卓越研究中心:疟疾研究
基本信息
- 批准号:7732710
- 负责人:
- 金额:$ 139.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AffectAfricaAfricanAnopheles gambiaeAnti-malarial drug resistanceAreaBehaviorBehavioralBiologyChloroguanideChloroquine resistanceCodeCollaborationsCulicidaeCutaneous LeishmaniasisDeveloped CountriesDeveloping CountriesDiseaseDoctor of PhilosophyEcologyEpidemiologyErythrocytesEuropeEvaluationFacultyFansidarFetal HemoglobinGenesGeneticGoalsHemoglobinHumanHygieneImmunologyLaboratoriesLeishmaniasisLondonMalariaMaliMedical EntomologyMethodologyModelingMolecular BiologyMolecular ProbesMutationNational Institute of Allergy and Infectious DiseaseOral MedicineParasitesPartner in relationshipPathologyPharmacy facilityPhlebotominaePhysiologicalPredispositionPurposePyrimethamineResearchResearch TrainingRoleSchoolsScienceScientistSiteTechnologyTestingTrainingTraining ProgramsTropical MedicineUnited States National Institutes of HealthUniversitiesWorkbasedesigninternational centermalemedical schoolsprogramsrapid detectionvector
项目摘要
The Laboratory of Malaria and Vector Research (LMVR) in cooperation with scientists at the National School of Medicine, Pharmacy and Odonto-Stomatology (FMPOS) of Mali conducts research at the Malaria Research and Training Center on the campus of the National School of Medicine of Mali and at the Faculty of Science and Technology in Bamako. The goals of these research programs are several. The primary goal is to develop and sustain a center of research excellance in Africa where the work is planned, directed and executed in close collaboration with African scientists. This goal has been essentially achieved and the MRTC is viewed as a model for research centers in developing countries.
A training program for MRTC staff continues to provide much needed expertise in all areas of biology tropical medicine, medical entomology and epidemiology with emphasis on molecular biology and immunology. Since its establishment in 1989, the NIAID has facilitated the graduate training of Malian staff at universities in the US and Europe. The LMVR program has research with Malian doctorates who have received additional PhD degrees at Tulane University (3), The University of Notre Dame (2), the London School of Hygiene and Tropical Medicine (1) and Oxford University (1). Several staff have received doctorates from the University of Bamako in cooperation and training from collaborators from the NIH and several US Universities.
Studies at the MRTC are focused on two main areas of emphasis; 1) The evaluation of and application of molecular probes developed in the LMVR which use PCR-based methodologies to detect the presence of genes in malaria parasites coding for resistance to anti-malarial drugs. Tests are now in place for the rapid detection of parasites resistant to chloroquine, pyrimethamine, proguanil and Fansidar. 2) Studies in Kangaba-Kela have focused on the role of various hemoglobin mutations in the human erythrocyte including Hemoglobins F, S and C in affecting the pathology of the disease. Studies in Kenieroba region are attempting to determine genetic and immunological predisposition to severe and complicated malaria.
The LMVR program on Leishmaniasis and its sandfly vectors is designed to describe the essentially unexamined epidemiology of cutaneous Leishmaniasis in Mali. Based at the MRTC and various field sites, this program has examined the epidemiology of the diseseas and the ecology of the sandfly vector.
The LMVR has expanded its research program on the ecology of anopheline malaria vectors in Mali with emphasis on the determination of physiological and behavioral factors which impact on the genetic isolation of the various chromosomal forms of the more important vectors. Mating behavior and swarming of male mosquitoes is being examined as a pre-zygotic mechanism for genetic isolation of various forms of Anopheles gambiae in Mali
疟疾和媒介研究实验室(LMVR)与马里国立医学、药学和口腔医学学院(FMPOS)的科学家合作,在马里国立医学院校园内的疟疾研究和培训中心开展研究马里和巴马科科学技术学院。这些研究计划的目标有几个。主要目标是在非洲发展和维持一个卓越的研究中心,该中心的工作是与非洲科学家密切合作规划、指导和执行的。这一目标已基本实现,MRTC 被视为发展中国家研究中心的典范。
MRTC 工作人员的培训计划继续提供生物学热带医学、医学昆虫学和流行病学所有领域急需的专业知识,重点是分子生物学和免疫学。自 1989 年成立以来,NIAID 一直致力于促进马里工作人员在美国和欧洲大学的研究生培训。 LMVR 项目与马里博士进行研究,他们在杜兰大学 (3)、圣母大学 (2)、伦敦卫生与热带医学学院 (1) 和牛津大学 (1) 获得了额外的博士学位。几名工作人员在美国国立卫生研究院和几所美国大学的合作者的合作和培训下获得了巴马科大学的博士学位。
MRTC 的研究主要集中在两个重点领域: 1) LMVR 中开发的分子探针的评估和应用,该探针使用基于 PCR 的方法来检测疟疾寄生虫中编码抗疟疾药物抗性的基因的存在。目前正在进行快速检测对氯喹、乙胺嘧啶、氯胍和 Fansidar 具有抗药性的寄生虫的测试。 2) Kangaba-Kela 的研究重点关注人类红细胞中各种血红蛋白突变(包括血红蛋白 F、S 和 C)在影响疾病病理学方面的作用。凯尼罗巴地区的研究正试图确定严重和复杂疟疾的遗传和免疫倾向。
关于利什曼病及其白蛉媒介的 LMVR 计划旨在描述马里皮肤利什曼病基本上未经审查的流行病学。该项目以 MRTC 和各个现场为基地,研究了疾病的流行病学和白蛉媒介的生态学。
LMVR 扩大了马里按疟疾媒介生态学的研究计划,重点是确定影响更重要媒介的各种染色体形式的遗传分离的生理和行为因素。正在研究雄性蚊子的交配行为和成群结队,作为马里各种形式冈比亚按蚊基因分离的合子前机制
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas E Wellems其他文献
Thomas E Wellems的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas E Wellems', 18)}}的其他基金
GENETICS OF DRUG RESISTANCE AND PATHOGENIC MECHANISMS IN P FALCIPARUM MALARIA
恶性疟的耐药遗传学及致病机制
- 批准号:
6098943 - 财政年份:
- 资助金额:
$ 139.07万 - 项目类别:
Genetics Of Drug Resistance, Antigenic Variation And Dis
耐药性、抗原变异和疾病的遗传学
- 批准号:
6669476 - 财政年份:
- 资助金额:
$ 139.07万 - 项目类别:
Drug Resistance/Antigenic Variation & Severity--Malaria
耐药性/抗原变异
- 批准号:
7192852 - 财政年份:
- 资助金额:
$ 139.07万 - 项目类别:
Drug Resistance, Antigenic Variation And Disease Severit
耐药性、抗原变异和疾病严重程度
- 批准号:
7299938 - 财政年份:
- 资助金额:
$ 139.07万 - 项目类别:
相似国自然基金
抗体依赖性增强效应介导非洲猪瘟病毒致病的分子机制
- 批准号:32373024
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于非洲猪瘟病毒pS273R蛋白泛素-蛋白酶体降解途径阻抑机制理性设计其特异性蛋白水解靶向嵌合体的研究
- 批准号:32373044
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
自噬在呋虫胺致非洲爪蟾脂质代谢紊乱中的调控机制研究
- 批准号:42307363
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
柠檬提取物抗非洲猪瘟的作用机理研究
- 批准号:32302853
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
中国国际发展合作在非洲的经济社会效益的研究
- 批准号:72303009
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Genetic and Environmental Influences on Individual Sweet Preference Across Ancestry Groups in the U.S.
遗传和环境对美国不同血统群体个体甜味偏好的影响
- 批准号:
10709381 - 财政年份:2023
- 资助金额:
$ 139.07万 - 项目类别:
Developing Botswana Laboratory Capacity in HIV Genomics and HIV Cure
发展博茨瓦纳艾滋病毒基因组学和艾滋病毒治疗实验室能力
- 批准号:
10688320 - 财政年份:2023
- 资助金额:
$ 139.07万 - 项目类别:
Screening strategies for sexually transmitted infections in a high HIV incidence setting in South Africa
南非艾滋病毒高发地区的性传播感染筛查策略
- 批准号:
10761853 - 财政年份:2023
- 资助金额:
$ 139.07万 - 项目类别:
Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
- 批准号:
10706874 - 财政年份:2023
- 资助金额:
$ 139.07万 - 项目类别:
SAIA-TB: Using the Systems Analysis and Improvement Approach (SAIA) to prevent TB in rural South Africa
SAIA-TB:使用系统分析和改进方法 (SAIA) 预防南非农村地区的结核病
- 批准号:
10699071 - 财政年份:2023
- 资助金额:
$ 139.07万 - 项目类别: